Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2005-11-17
2010-12-07
Marvich, Maria B (Department: 1633)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S325000, C435S069100, C435S455000
Reexamination Certificate
active
07846732
ABSTRACT:
The present invention relates to a method of sequence-specific recombination of DNA in eukaryotic cells, comprising the introduction of a first DNA comprising a nucleotide sequence containing at least one recombination sequence into a cell, introducing a second DNA comprising a nucleotide sequence containing at least one further recombination sequence into a cell, and performing the sequence specific recombination by a bacteriophage lambda integrase Int.
REFERENCES:
patent: 2002/0007051 (2002-01-01), Cheo et al.
patent: 2003/0027337 (2003-02-01), Droge et al.
patent: 2003/0226164 (2003-12-01), Suttie et al.
patent: WO 01/16345 (2001-03-01), None
Christ and Dröge, “Alterations in the directionality of λ site-specific recombination catalyzed by mutant mtegrases in vivo,”J. Mol. Biol., 288:825-836, 1999.
Christ and Droge, “Alterations in the directionality of lambda site-specific recombination catalyzed by mutant integrasses in vivo,”J. Mol. Biol. 288:825-836, 1998.
Christ and Dröge, “Genetic manipulation of mouse embryonic stem cells by mutant λ integrase,”Genesis, 32:203-208, 2002.
Christ et al., “Site-specific recombination in eukaryotic cells mediated by mutant λ integrases: implications for synaptic complex formation and the reactivity of episomal DNA segments,”J. Mol. Biol., 319:305-314, 2002.
Gu et al., “Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting,” Science, 265:103-106, 1994.
Hoess et al., “Mechanism of strand cleavage and exchange in the Cre-Iox site-specific recombination system,”J. Mol. Biol., 181:351-362, 1985.
Jefferis, “Glycosylation of human IgG antibodies relevance to therapeutic applications,”BioParm, pp. 1-6, 2001.
Kilby et al., “Site-specific recombinases: tools for genome engineering,”Trends Genet., 9:413-421, 1993.
Kühn et al., “Inducible gene targeting in mice,”Science, 269:1427-1429, 1995.
Lorbach et al. “Site-specific recombination in human cells catalyzed by phage lambda integrase mutants,”J. Mol. Biol., 296:1175-1181, 2000.
Lorbach et al., “Site-specific recombination in human cells catalyzed by phage λ integrase mutants,”J. Mol. Biol., 296:1175-1181, 2000.
Müller, “Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis,”Mech. Develop., 82:3-21, 1999.
Schwikardi et al., “Site-specific recombination in mammalian cells catalyzed by γδ resolvase mutants: implications for the topology of episomal DNA,”FEBS Letters, 471:147-150, 2000.
Dröge Peter
Enenkel Barbara
Boehringer Ingelheim Pharma KG
Dröge Peter
Fulbright & Jaworski L.L.P.
Marvich Maria B
LandOfFree
Sequence specific DNA recombination in eukaryotic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sequence specific DNA recombination in eukaryotic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sequence specific DNA recombination in eukaryotic cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4222104